Catalyst Pharmaceuticals ... (CPRX)
NASDAQ: CPRX
· Real-Time Price · USD
23.66
0.13 (0.55%)
At close: Jun 16, 2025, 3:59 PM
23.59
-0.27%
After-hours: Jun 16, 2025, 07:57 PM EDT
0.55% (1D)
| Bid | 20.23 |
| Market Cap | 2.89B |
| Revenue (ttm) | 534.65M |
| Net Income (ttm) | 197.35M |
| EPS (ttm) | 1.57 |
| PE Ratio (ttm) | 15.07 |
| Forward PE | 13.43 |
| Analyst | Buy |
| Ask | 27.27 |
| Volume | 831,717 |
| Avg. Volume (20D) | 1,285,130 |
| Open | 23.53 |
| Previous Close | 23.53 |
| Day's Range | 23.39 - 23.91 |
| 52-Week Range | 14.75 - 26.58 |
| Beta | 0.72 |
About CPRX
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol CPRX
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for CPRX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts1 month ago
-2.98%
Catalyst Pharmaceuticals shares are trading lower ...
Unlock content with
Pro Subscription
2 months ago
-1.88%
Catalyst Pharmaceuticals shares are trading higher after the company announced that Health Canada accepted its AGAMREE new drug submission with priority review.
